although
less
known
abil
antibodi
mediat
demyelin
presenc
oligoclon
expand
b
cell
high
concentr
antibodi
self
infecti
agent
central
nervou
system
mani
multipl
sclerosi
patient
suggest
antibodi
may
also
contribut
myelin
destruct
show
antijhm
antibodi
absenc
b
cell
caus
demyelin
jhminfect
mice
antijhm
antibodi
detect
adjac
area
demyelin
consist
direct
interact
antibodi
infect
cell
demyelin
reduc
infect
mice
lack
normal
express
activ
fc
receptor
complement
deplet
treatment
cobra
venom
factor
data
demonstr
jhmspecif
antibodi
suffici
caus
demyelin
myelin
destruct
presenc
antiviru
antibodi
result
combin
complementand
fc
receptordepend
mechan
j
pathol
human
diseas
multipl
sclerosi
ms
immunemedi
chronic
inflammatori
diseas
manifest
clinic
neurolog
deficit
histolog
multipl
foci
demyelin
cell
detect
activ
demyelin
lesion
critic
role
cell
demyelin
clearli
demonstr
sever
anim
model
demyelin
includ
rodent
experiment
autoimmun
enceph
eae
mice
infect
coronavirus
theiler
murin
encephalomyel
viru
mice
infect
neurotrop
jhm
strain
mous
hepat
viru
jhm
develop
acut
chronic
demyelin
diseas
other
shown
demyelin
detect
jhminfect
mice
lack
b
cell
either
mice
sever
combin
immunodefici
mice
lack
function
recombin
activ
enzym
howev
adopt
transfer
syngen
splenocyt
jhmimmun
mice
result
rapid
reproduc
demyelin
deplet
cell
abrog
demyelin
show
cell
necessari
b
splenic
cell
suffici
demyelin
occur
either
cell
absenc
subset
abl
mediat
demyelin
model
experi
cell
transfer
mice
day
immun
jhm
innat
immun
system
activ
jhm
infect
tcell
transfer
shown
upregul
express
sever
proinflammatori
cytokin
chemokin
tumor
necrosi
rant
central
nervou
system
cn
intens
inflammatori
milieu
like
critic
rapid
recruit
activ
cell
cn
adopt
transfer
less
known
role
humor
immun
factor
ms
sever
featur
suggest
b
cell
antibodi
involv
myelin
destruct
oligoclon
expans
b
cell
observ
cerebrospin
fluid
patient
ms
also
high
level
immunoglobulin
detect
cerebrospin
fluid
cerebrospin
fluidderiv
antibodi
direct
myelin
protein
pathogen
epsteinbarr
viru
varicellazost
viru
addit
circul
antibodi
myelin
protein
detect
patient
ms
marker
subsequ
develop
ms
patient
singl
episod
first
neurolog
event
furthermor
deposit
igg
complement
detect
site
activ
demyelin
patient
multipl
studi
use
rodent
model
eae
also
indic
antibodi
may
import
role
demyelin
process
mice
rat
marmoset
treatment
antibodi
direct
epitop
myelin
oligodendrocyt
glycoprotein
result
rapid
onset
demyelin
antibodi
detect
site
myelin
destruct
mechan
antibodymedi
demyelin
known
certainti
sever
studi
show
complement
deplet
cobra
venom
factor
cvf
result
delay
onset
eae
reduct
demyelin
eae
report
amelior
unaffect
mice
defici
express
studi
implic
role
termin
compon
complement
demyelin
via
format
membran
attack
complex
mac
mac
multipl
function
includ
direct
cell
lysi
enhanc
phagocytosi
fc
receptor
fcr
involv
interact
antibodi
effector
cell
includ
macrophag
also
implic
antibodyinduc
demyelin
mice
defici
express
activ
fcr
develop
less
diseas
demyelin
wherea
diseas
exacerb
mice
lack
express
inhibitori
molecul
studi
suggest
antibodi
direct
cn
antigen
mediat
demyelin
process
involv
signal
fcr
complement
activ
howev
studi
alway
perform
anim
intact
tand
bcell
compart
make
difficult
determin
precis
role
antibodi
demyelin
process
exampl
increas
express
adhes
molecul
serv
chemoattract
macrophag
cell
also
requir
optim
tcell
activ
treatment
mice
antagonist
result
diminish
tcell
respons
therefor
administr
antimyelin
oligodendrocyt
glycoprotein
antibodi
may
initi
demyelin
process
demyelin
may
primarili
cellmedi
complement
activ
serv
enhanc
tcell
respons
previou
result
show
inflammatori
state
exist
cn
jhminfect
mice
demyelin
detect
absenc
transfer
cell
consequ
model
excel
determin
whether
transfer
antiviru
antibodi
absenc
transfer
b
cell
suffici
mediat
demyelin
pathogenfre
mice
purchas
nation
cancer
institut
bethesda
md
specif
pathogenfre
mice
purchas
jackson
laboratori
bar
harbor
bred
univers
iowa
iowa
citi
ia
mice
gener
gift
dr
timothi
ratliff
univers
iowa
bred
mice
gener
mice
control
group
experi
use
mice
agematch
litterm
heterozyg
use
sixto
eightweekold
anim
use
studi
anim
studi
approv
univers
iowa
anim
care
use
committe
preliminari
experi
determin
g
mab
administ
intraperiton
day
infect
result
maximum
demyelin
consequ
g
mab
per
mous
administ
except
note
experi
adopt
transfer
splenocyt
mice
previous
immun
intraperiton
jhm
infect
mice
perform
previous
describ
viru
titer
describ
previous
briefli
anim
sacrif
perfus
steril
pb
tissu
homogen
ml
pb
two
cycl
freezethaw
supernat
obtain
centrifug
g
minut
supernat
assay
viru
plaqu
assay
hela
cell
express
cellular
receptor
mous
hepat
viru
helamhvr
viral
titer
repres
pfug
brain
sem
deplet
complement
vivo
cvf
isol
naja
naja
kaaouthia
gkg
calbiochem
la
jolla
ca
administ
intraperiton
l
pb
begin
day
antibodi
inject
day
infect
jhm
everi
day
thereaft
mice
harvest
control
mice
receiv
pb
alon
mice
perfus
pb
spinal
cord
fix
zinc
formalin
labesco
solon
oh
overnight
embed
paraffin
eightm
longitudin
section
entir
spinal
cord
prepar
stain
luxol
fast
blue
quantif
demyelin
spinal
cord
section
photograph
digit
use
leitz
dmb
microscop
leica
microscop
wetzler
germani
optron
digit
camera
optron
goleta
ca
demyelin
quantifi
use
imagej
softwar
nation
institut
health
bethesda
md
describ
previous
data
repres
fraction
total
white
matter
spinal
cord
show
demyelin
averag
demyelin
per
group
repres
arithmet
mean
valu
sem
eightm
section
prepar
zinc
formalinfix
spinal
cord
permeabil
triton
section
treat
ca
block
zyme
laboratori
south
san
francisco
ca
incub
primari
antibodi
detect
macrophagesmicroglia
rat
ci
serotec
oxford
england
viral
antigen
mous
antin
overnight
wash
section
incub
biotinyl
goat
antirat
antimous
n
antibodi
jackson
immunoresearch
west
grove
pa
dilut
hour
room
temperatur
follow
avidinhorseradish
peroxidas
section
develop
sigma
chemic
immunofluoresc
assay
section
incub
overnight
cocktail
mous
antiphosphoneurofila
mab
sternberg
monoclon
luthervil
md
biotinyl
goat
antirabbit
igg
jackson
immunoresearch
wash
sampl
incub
fluorescein
isothiocyanateconjug
antimous
igg
jackson
immunoresearch
jackson
immunoresearch
examin
fluoresc
microscopi
twotail
unpair
student
ttest
use
analyz
differ
mean
valu
group
initi
investig
whether
polyclon
rabbit
antijhm
antibodi
could
mediat
demyelin
jhminfect
mice
jhminfect
mice
surviv
day
inocul
develop
signific
level
demyelin
preliminari
experi
determin
l
rabbit
polyclon
antibodi
deliv
intraperiton
day
infect
result
signific
amount
demyelin
wherea
administr
normal
rabbit
sera
tabl
figur
antijhm
normal
rabbit
sera
prolong
surviv
mice
receiv
normal
sera
develop
symptom
sever
enceph
hunch
lethargi
ruffl
fur
day
infect
euthan
mice
time
detect
demyelin
mice
receiv
antijhm
sera
detect
recipi
normal
rabbit
sera
p
demyelin
accompani
infiltr
macrophagesmicroglia
white
matter
spinal
cord
figur
b
e
detect
viral
antigen
throughout
spinal
cord
mice
except
area
demyelin
figur
c
f
similar
lack
viru
antigen
area
myelin
destruct
also
observ
model
jhminduc
demyelin
suggest
demyelina
mice
receiv
either
rabbit
sera
mous
mab
day
infect
harvest
day
infect
valu
shown
mean
sem
demyelin
significantli
higher
viru
titer
lower
mice
receiv
antijhm
rabbit
sera
p
p
respect
demyelin
significantli
differ
recipi
mab
p
mab
p
mab
p
compar
recipi
antiklh
mab
tion
consequ
viru
clearanc
begin
understand
mechan
antibodyinduc
demyelin
examin
spinal
cord
section
antibodytr
infect
mice
antibodi
deposit
unabl
detect
antibodi
cn
mice
receiv
l
antibodi
howev
demyelin
also
detect
mice
receiv
l
rabbit
antijhm
antibodi
abl
detect
deposit
antibodi
adjac
site
demyelin
elsewher
mice
figur
g
antibodi
function
directli
cn
would
like
recogn
viral
protein
surfac
infect
cell
next
test
panel
five
antijhm
mab
recogn
n
protein
abil
mediat
demyelin
infect
mice
tabl
protein
abund
jhm
protein
present
infect
cell
surfac
would
predict
target
antijhm
demyelin
antibodi
n
protein
predict
lack
surfac
express
howev
previou
report
suggest
nand
mspecif
antibodi
epitop
express
cell
surfac
mice
receiv
irrelev
antibodi
antiklh
pb
develop
insignific
amount
demyelin
tabl
comparison
jhminfect
recipi
jhmimmun
splenocyt
exhibit
similar
amount
demyelin
although
kinet
myelin
destruct
rapid
demyelin
detect
day
infect
figur
demyelin
mab
mice
reflect
differ
viru
clearanc
similar
amount
viru
detect
recipi
antijhm
mab
pb
irrelev
antibodi
tabl
inabl
detect
differ
viru
titer
presenc
prolong
surviv
may
reflect
transient
reduct
viru
titer
earli
time
infect
expect
histolog
examin
section
mab
mice
reveal
presenc
activ
macrophagesmicroglia
adjac
demyelin
area
data
shown
quantifi
number
macrophagesmicroglia
antibodi
transfer
count
number
macrophagesmicroglia
gray
white
matter
midsagitt
section
spinal
cord
three
mice
receiv
either
mab
irrelev
antibodi
experi
cell
crosssect
level
within
spinal
cord
count
number
macrophagesmicroglia
present
per
crosssect
area
increas
threefold
infus
antijhm
antibodi
compar
receiv
control
antibodi
versu
p
addit
infiltr
cell
local
entir
white
matter
model
jhminduc
demyelin
primari
secondari
axon
damag
similarli
demyelin
induc
antijhm
antibodi
primari
intact
axon
detect
travers
area
demyelin
figur
k
l
examin
whether
induct
demyelin
antibodi
transfer
uniqu
mab
four
addit
mab
analyz
mab
anti
mab
anti
mab
antim
mab
antin
tabl
none
antibodi
regardless
specif
exhibit
protect
effect
mice
moribund
day
infect
g
administ
result
expect
mab
high
neutral
antibodi
titer
prdmg
report
protect
mice
enceph
found
howev
mab
ineffici
compar
mab
protect
mice
acut
enceph
inocul
neurovirul
jhm
data
shown
mice
receiv
g
mab
show
clinic
sign
demyelin
includ
difficulti
right
hindlimb
paresi
demyelin
detect
histolog
examin
within
rang
demyelin
observ
mice
treat
mab
harvest
time
infect
increas
amount
mab
administ
g
prolong
mous
surviv
day
infect
result
clinic
outcom
amount
demyelin
figur
kinet
demyelin
mediat
either
jhmimmun
splenocyt
oe
jhmspecif
mab
mice
infect
jhm
demyelin
minim
jhminfect
mice
untreat
howev
rapid
robust
demyelin
n
observ
day
transfer
jhmimmun
splenocyt
previous
describ
demyelin
also
detect
day
jhmimmun
splenocyt
enrich
either
n
n
oe
cell
transfer
jhminfect
mice
demyelin
develop
rapidli
treatment
anti
mab
reach
similar
level
day
infus
n
n
indistinguish
mice
treat
mab
also
harvest
day
infect
anoth
anti
antibodi
mab
neutral
vitro
mediat
demyelin
singl
antim
antibodi
analyz
also
mediat
demyelin
infect
mice
tabl
although
protein
primarili
intern
viral
protein
least
one
antim
mab
shown
neutral
jhm
infect
vitro
protect
mice
acut
enceph
consist
surfac
express
present
known
whether
epitop
recogn
mab
expos
infect
cell
surfac
transfer
g
antibodi
specif
either
n
klh
infect
mice
prolong
surviv
result
increas
demyelin
compar
mice
receiv
antibodi
tabl
thirti
g
antin
antibodi
treatment
prolong
surviv
result
demyelin
two
nine
mice
may
reflect
antibodi
access
nucleocapsid
protein
anim
begin
delin
mechan
antibodymedi
demyelin
first
determin
role
activ
fcr
process
purpos
gener
mice
mice
defici
express
addit
lack
b
cell
therefor
use
investig
role
fcrdepend
pathway
antibodyinduc
demyelin
mice
express
much
wildtyp
mice
exhibit
impair
phagocyt
function
preliminari
experi
observ
mice
slightli
resist
jhm
infect
mice
surviv
day
longer
although
demyelin
develop
mice
differ
may
reflect
differ
genet
lineag
mice
obtain
background
consequ
heterozyg
litterm
infect
control
potenti
genet
differ
mice
suscept
jhm
litterm
death
occur
day
versu
day
infect
basi
differ
understood
antibodi
present
anim
enhanc
suscept
jhm
even
evid
treatment
mab
mice
moribund
day
infect
wherea
jhminfect
mice
surviv
greater
day
infect
mice
therefor
examin
viral
load
demyelin
cn
day
infect
tabl
mab
mice
develop
clinic
sign
acut
enceph
hunch
lethargi
ruffl
fur
time
contrast
mab
mice
litter
exhibit
primarili
hindlimb
weak
consist
clinic
observ
demyelin
mice
significantli
reduc
compar
control
versu
p
tabl
result
explain
differ
viru
titer
similar
amount
infecti
viru
present
mice
tabl
describ
complement
key
compon
rodent
model
antibodyinduc
eae
addit
recent
studi
show
antibodymedi
autoimmun
diseas
depend
intact
complement
fcr
pathway
maxim
diseas
express
consequ
next
evalu
role
complement
antijhm
antibodyinduc
demyelin
use
cvf
homolog
deplet
complement
mice
treat
cvf
dosag
frequenc
shown
previous
result
complement
deplet
gkg
begin
day
antibodi
inject
everi
day
thereaft
cvf
treatment
presenc
mab
alter
surviv
mice
becom
moribund
day
infect
similar
mice
receiv
antibodi
howev
mice
treat
cvf
show
clinic
sign
enceph
includ
hunch
lethargi
ruffl
fur
sign
demyelin
difficulti
right
hindlimb
paresi
compar
control
mice
cvf
treatment
result
slight
increas
viru
titer
cn
log
pfug
brain
versu
log
pfug
brain
p
quantif
demyelin
reveal
reduct
cvf
treatment
compar
pbstreat
anim
versu
p
tabl
amount
demyelin
greater
experi
mice
treat
g
antimhv
mab
mab
day
infect
valu
shown
mean
sem
mice
significantli
demyelin
mice
p
cvftreat
mice
significantli
less
demyelin
significantli
higher
viru
titer
control
mice
p
p
respect
describ
mice
sampl
day
later
infect
figur
previous
other
show
infus
cell
jhminfect
sever
combin
immunodefici
mice
result
demyelin
studi
extend
result
show
antijhm
antibodi
absenc
cell
also
abl
mediat
demyelin
experiment
system
infus
antiklh
antibodi
normal
rabbit
sera
caus
demyelin
show
nonspecif
bind
infect
cell
fcr
macrophag
inadequ
initi
process
furthermor
antiviru
antibodi
abl
mediat
demyelin
draw
firm
conclus
characterist
antiviru
antibodi
allow
mediat
demyelin
limit
number
examin
studi
like
viral
epitop
recogn
demyelin
antibodi
must
express
cell
surfac
although
formal
proven
mab
antim
mab
abl
induc
demyelin
one
anti
antibodi
mab
mediat
demyelin
mab
may
demyelin
iga
antibodi
epitop
recogn
fulli
access
nativ
glycoprotein
antibodyinduc
demyelin
occur
infect
neuroattenu
variant
jhm
use
studi
robust
demyelin
occur
antijhm
antibodytr
mice
intranas
infect
pfu
parent
neurovirul
jhm
strain
instanc
larger
amount
antibodi
g
mab
requir
enhanc
surviv
demyelin
n
observ
day
infect
addit
matthew
colleagu
show
strain
mous
hepat
viru
also
induc
substanti
amount
demyelin
mice
infect
presenc
virusspecif
hyperimmun
serum
antibodi
capabl
initi
myelin
destruct
may
function
one
mechan
virusspecif
antibodi
may
directli
interact
infect
cell
cn
therebi
result
express
chemoattract
macrophagesmicroglia
consist
possibl
antijhm
antibodi
detect
site
demyelin
figur
chemotact
inflammatori
identifi
crucial
macrophagemicroglia
infiltr
eae
implic
macrophag
infiltr
jhminfect
cn
howev
chemokin
express
high
level
jhminfect
cn
unabl
detect
differ
express
chemokin
tcell
transfer
correl
extent
demyelin
thu
chemokin
import
antibodymedi
demyelin
like
local
differ
express
rather
substanti
chang
total
product
cn
altern
antibodi
may
bind
circul
viru
antigen
result
immun
complex
may
activ
macrophag
peripheri
milieu
jhminfect
cn
proinflammatori
peripher
activ
may
requir
demyelin
occur
preced
come
eae
studi
peripher
activ
macrophag
critic
develop
diseas
complement
pathway
implic
antibodymedi
demyelin
jhminfect
mice
least
mab
infus
mab
antibodi
subclass
activ
complement
poorli
classic
pathway
conceiv
rel
contribut
pathway
demyelin
would
chang
antibodi
effect
fix
complement
use
role
complement
autoimmun
diseas
includ
eae
remain
controversi
partli
effect
complement
pleiotrop
studi
suggest
earli
compon
complement
pathway
critic
may
function
opsonin
myelin
therebi
enhanc
phagocytosi
macrophag
chemoattract
monocytesmacrophag
therebi
may
directli
contribut
influx
cell
white
matter
complement
product
anaphylatoxin
multipl
proinflammatori
effect
macrophag
includ
enhanc
differenti
cytokin
releas
addit
via
bind
enhanc
express
activ
diminish
inhibitori
properti
may
contribut
requir
complementand
fcrdepend
pathway
maxim
demyelin
jhminfect
mice
studi
use
rodent
defici
express
suggest
format
mac
critic
demyelin
antibodyinduc
eae
demyelin
inflammatori
cell
infiltr
greatli
reduc
rat
eae
mac
directli
damag
infect
oligodendrocyt
may
contribut
inflammatori
cascad
result
macrophag
infiltr
demyelin
jhminfect
mice
mac
sublyt
amount
may
also
contribut
inflamm
activ
target
cell
also
critic
antibodyinduc
demyelin
jhminfect
mice
although
may
involv
antigen
present
function
unlik
import
mice
like
macrophagesmicroglia
activ
via
immunoreceptor
tyrosinebas
activ
motif
present
chain
activ
activ
via
may
enhanc
recruit
macrophagesmicroglia
infect
white
matter
also
may
involv
releas
cytokin
includ
tumor
necrosi
releas
substanc
oxygen
radic
may
directli
damag
myelin
requir
complementand
pathway
demonstr
antibodymedi
patholog
condit
includ
immun
complexmedi
skin
lung
diseas
inflammatori
arthriti
collect
studi
suggest
antibodi
bind
infect
oligodendrocyt
lead
gener
format
mac
well
activ
macrophagesmicroglia
via
fcrdepend
pathway
result
increas
migrat
cell
white
matter
spinal
cord
subsequ
destruct
infect
oligodendrocyt
myelin
result
emphas
multifactori
complex
natur
demyelin
process
although
cell
gener
respons
bulk
immunemedi
myelin
damag
experiment
model
either
cell
antibodi
direct
antigen
present
cn
jhm
experi
also
mediat
demyelin
patient
ms
cell
also
believ
critic
develop
inflamm
howev
igg
complement
deposit
detect
demyelin
lesion
ms
lesion
consist
role
myelin
destruct
also
implic
initi
stage
demyelin
process
result
show
appropri
circumst
antibodi
absenc
cell
caus
demyelin
